Cardiawave has obtained clinical trial authorizations for its non-invasive treatment of aortic stenosis.
Authorizations have been granted by ethical committees and competent authorities to begin clinical trials in France and the Netherlands, with imminent approval in Serbia as well. A trial in 10 patients will therefore commence shortly.
Full article available on DotMed.com ⬇️
https://fr.dotmed.com/news/story/46800
Our testimony and advice as recently winners of PME Instrument Phase 2, along with Medicen Paris Region:
Cardiawave will attend ICI meeting 2018 in Israël, the international meeting for innovation in cardiovascular systems from Decembre 2nd to 4th, 2018!
Cardiawave will attend Bohemian Medical Device Summit in Prague, from December 5th to 7th 2018 !
Discover the publication of the works of Daniel Suarez Escudero, biomedical imaging engineer at Cardiawave, about cavitation imaging for Pulsed cavitation ultrasound therapy in Physics and Biology:
http://iopscience.iop.org/article/10.1088/1361-6560/aaef68/meta
We’ve been selected as one of Hello Tomorrow Global Summit Top 500 deeptech startups from over 4,500 applications from 119 countries!
Come and meet us at the The Hello Tomorrow Global Summit in Paris on 14-15th March 2019:
http://www.hello-tomorrow.org/summit
On the occasion of the 2018 IEEE International Ultrasonics Symposium in Japan, cardiologist Guillaume Goudot presents today a poster about work carried out by the Hôpital Européen Georges Pompidou, the Langevin Institute and Cardiawave.
Cardiawave is attending Medtech Conference in Philadelphia, from September 24th to 26th 2018.
